Skip to content

Cranberry Juice for Treatment of Urinary Tract Infections

Cranberry Juice and Urinary Tract Infections

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00093054
Enrollment
319
Registered
2004-10-01
Start date
2004-11-30
Completion date
2009-12-31
Last updated
2015-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Keywords

Vaccinium macrocarpon

Brief summary

The purpose of this study is to determine whether daily consumption of cranberry juice lessens the symptoms and prevents the recurrence of urinary tract infections (UTIs). This study will also determine whether drinking cranberry juice for 6 months selects for less virulent bacteria in the rectal, vaginal, and urethral areas.

Detailed description

Participants in this study will be randomly assigned to consume either 8 ounces of cranberry juice or placebo juice twice a day for 6 months. Participants will have follow-up visits at 3 and 6 months, and whenever they experience a symptomatic episode. Urine, vaginal and rectal specimens will be taken at each visit to test for the presence of bacteria that cause urinary tract infections. Participants will complete a questionnaire at study entry, Day 3, Weeks 1 and 2, and monthly thereafter or whenever there is a recurrence of symptoms.

Interventions

TID dosage for UTI treatment

DIETARY_SUPPLEMENTPlacebo cranberry juice

TID placebo dosage to match active comparator

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Culture-confirmed urinary tract infection at study start

Exclusion criteria

* Other chronic disease * Antibiotics within 48 hours prior to study start * Hospitalization for any reason within 2 weeks prior to study start * Stones in urinary tract * Plans to leave Ann Arbor within 6 months after study start * Allergy to cranberry or cranberry compounds * Pregnancy

Design outcomes

Primary

MeasureTime frame
Cultureper visit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026